MTEM Insider Trading
Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 13.90%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
Molecular Templates Share Price & Price History
Current Price: $0.00
Price Change: +0.30 (1.20%)
As of 05/30/2025 01:00 AM ET
Molecular Templates Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 11/14/2024 | Target N. V. Biotech | Major Shareholder | Sell | 1,279,820 | $0.66 | $844,681.20 | | |
| 4/2/2024 | Target N V Biotech | Major Shareholder | Buy | 250,000 | $2.35 | $587,500.00 | 1,279,820 | |
| 7/17/2023 | Target N V Biotech | Major Shareholder | Buy | 283,687 | $7.05 | $1,999,993.35 | 1,029,821 | |
Molecular Templates Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 5/16/2024 | BVF Inc. IL | 522,238 | $1.17M | 0.0% | -1.8% | 7.937% |  |
| 2/12/2024 | Monashee Investment Management LLC | 121,841 | $0.45M | 0.1% | -14.1% | 2.269% |  |
| 11/15/2023 | Adage Capital Partners GP L.L.C. | 292,764 | $1.85M | 0.0% | -75.6% | 5.442% |  |
| 11/14/2023 | Monashee Investment Management LLC | 141,841 | $0.90M | 0.4% | N/A | 2.636% |  |
| 11/13/2023 | Acadian Asset Management LLC | 10,937 | $67K | 0.0% | -93.3% | 0.203% |  |
| 11/13/2023 | Silverarc Capital Management LLC | 354,608 | $2.24M | 0.7% | N/A | 6.591% |  |
| 11/3/2023 | Carlyle Group Inc. | 13,333 | $84K | 0.0% | -93.3% | 0.248% |  |
| 8/7/2023 | Acadian Asset Management LLC | 164,085 | $78K | 0.0% | -30.0% | 0.291% |  |
| 5/5/2023 | Carlyle Group Inc. | 200,000 | $75K | 0.0% | N/A | 0.355% |  |
| 11/10/2022 | Kingsbury Capital Investment Advisors LLC | 298,638 | $0.22M | 0.3% | +732.5% | 0.530% |  |
| 8/9/2022 | Pictet Asset Management SA | 2,903,180 | $2.65M | 0.0% | -9.5% | 5.153% |  |
| 8/9/2022 | Kingsbury Capital Investment Advisors LLC | 35,873 | $33K | 0.0% | +58.5% | 0.064% |  |
| 5/17/2022 | Endurant Capital Management LP | 314,238 | $1.08M | 0.3% | +17.1% | 0.558% |  |
| 5/16/2022 | Frazier Life Sciences Management L.P. | 1,374,047 | $4.74M | 0.4% | N/A | 2.440% |  |
| 5/12/2022 | Connor Clark & Lunn Investment Management Ltd. | 20,560 | $71K | 0.0% | N/A | 0.037% |  |
| 5/5/2022 | Russell Investments Group Ltd. | 458,138 | $1.58M | 0.0% | +61.6% | 0.814% |  |
| 5/4/2022 | ClariVest Asset Management LLC | 158,900 | $0.55M | 0.0% | +20.7% | 0.282% |  |
| 3/3/2022 | Walleye Capital LLC | 155,449 | $0.61M | 0.0% | N/A | 0.276% |  |
| 2/15/2022 | Adage Capital Partners GP L.L.C. | 1,200,000 | $4.70M | 0.0% | +18.2% | 2.131% |  |
| 2/14/2022 | ClariVest Asset Management LLC | 131,679 | $0.52M | 0.0% | +45.2% | 0.234% |  |
| 2/14/2022 | GSA Capital Partners LLP | 145,329 | $0.57M | 0.1% | +274.3% | 0.258% |  |
| 2/11/2022 | Ensign Peak Advisors Inc | 140,767 | $0.55M | 0.0% | +33.7% | 0.250% |  |
| 2/10/2022 | Pictet Asset Management SA | 3,301,019 | $12.94M | 0.0% | -2.5% | 5.863% |  |
| 2/10/2022 | Acadian Asset Management LLC | 18,889 | $74K | 0.0% | N/A | 0.034% |  |
| 2/9/2022 | Dimensional Fund Advisors LP | 344,162 | $1.35M | 0.0% | +2.6% | 0.611% |  |
| 2/8/2022 | ProShare Advisors LLC | 16,009 | $63K | 0.0% | N/A | 0.028% |  |
| 2/8/2022 | Northern Trust Corp | 385,420 | $1.51M | 0.0% | -4.3% | 0.685% |  |
| 2/7/2022 | SG Americas Securities LLC | 12,046 | $47K | 0.0% | -36.7% | 0.021% |  |
| 1/21/2022 | Russell Investments Group Ltd. | 283,563 | $1.11M | 0.0% | +7.0% | 0.504% |  |
| 11/16/2021 | Two Sigma Advisers LP | 382,029 | $2.56M | 0.0% | +19.4% | 0.680% |  |
| 11/16/2021 | Two Sigma Investments LP | 308,964 | $2.07M | 0.0% | +175.4% | 0.550% |  |
| 11/15/2021 | Man Group plc | 106,684 | $0.72M | 0.0% | +27.9% | 0.190% |  |
| 11/15/2021 | California State Teachers Retirement System | 48,422 | $0.33M | 0.0% | -5.2% | 0.086% |  |
| 11/15/2021 | Dimensional Fund Advisors LP | 335,427 | $2.25M | 0.0% | -5.9% | 0.597% |  |
| 11/15/2021 | Ensign Peak Advisors Inc | 105,288 | $0.71M | 0.0% | N/A | 0.188% |  |
| 11/12/2021 | Renaissance Technologies LLC | 210,569 | $1.41M | 0.0% | N/A | 0.375% |  |
| 11/12/2021 | Hsbc Holdings PLC | 11,549 | $78K | 0.0% | N/A | 0.021% |  |
| 11/12/2021 | The Manufacturers Life Insurance Company | 15,235 | $0.10M | 0.0% | -34.6% | 0.027% |  |
| 11/12/2021 | Geode Capital Management LLC | 656,908 | $4.41M | 0.0% | -4.2% | 1.170% |  |
| 11/10/2021 | Goldman Sachs Group Inc. | 85,026 | $0.57M | 0.0% | +63.9% | 0.151% |  |
| 11/10/2021 | Citigroup Inc. | 4,765 | $32K | 0.0% | +100.4% | 0.008% |  |
| 11/9/2021 | BlackRock Inc. | 2,622,580 | $17.60M | 0.0% | -1.2% | 4.671% |  |
| 11/5/2021 | Advisor Group Holdings Inc. | 4,349 | $29K | 0.0% | +764.6% | 0.008% |  |
Data available starting January 2016
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States. The company develops therapies through its proprietary biologic drug platform technology (ETB). It is also developing MT- 8421, an ETB candidate that is in Phase I clinical trial for the treatment of dismantling TME through direct cell-kill of tumor and immune cell; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory multiple myeloma; and MT-6402 in that is in Phase I clinical trial for relapsed/refractory patients with PD-L1 expressing tumors. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.
Read More on Molecular Templates
Today's Range
Now: N/A
50 Day Range
MA: N/A
52 Week Range
Now: N/A
Volume
N/A
Average Volume
5,623,605 shs
Market Capitalization
$1 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.53
Who are the company insiders with the largest holdings of Molecular Templates?